>The AJM hasn't recommended anything. AJM has published a paper titled "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection".
>It hasn't published it "now". It has published it back in August of 2020.
"The American Journal of Medicine, Vol 134, No 1, January 2021", Page 18, shows a treatment algorithm for Covid-19-like and confirmed Covid-19 illness, specifying 200mg of Hydroxochloroquine for patients over the age of 50 or with a single comorbidity.
I'm not talking about the primary study on HCQ, but the treatment algorithm is recent.
"The American Journal of Medicine, Vol 134, No 1, January 2021", Page 18, shows a treatment algorithm for Covid-19-like and confirmed Covid-19 illness, specifying 200mg of Hydroxochloroquine for patients over the age of 50 or with a single comorbidity.
I'm not talking about the primary study on HCQ, but the treatment algorithm is recent.